Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a ‘Real-Life’ Setting

Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a ‘Real-Life’ Setting

There is lack of data addressing the intracranial (IC) efficacy of immune checkpoint inhibitors (ICIs) on brain metastases (BM) in non-small cell lung cancer (NSCLC). This patient category is underrepresented in randomized clinical trials. We retrospectively collected clinical data on patients with...

Full description

Bibliographic Details
Main Authors: Marcus Skribek, Konstantinos Rounis, Dimitrios Makrakis, Sofia Agelaki, Dimitris Mavroudis, Luigi De Petris, Simon Ekman, Georgios Tsakonas
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Cancers
Subjects:
immunotherapy
immune checkpoint inhibitors
advanced lung cancer
non-small cell lung cancer
brain metastases
Online Access:https://www.mdpi.com/2072-6694/12/12/3707

Internet

https://www.mdpi.com/2072-6694/12/12/3707

Similar Items